Consistently, a decrease in PDYN mRNA expression as well as in PDYN- and PENK-derived peptides has been reported in HD brains suggesting a combined effect of transcriptional dysregulation and loss of MSNs expressing PENK and PDYN genes [8, 9, 28–30]. This evidence concerns the gene PENK and Huntington disease.